Human mAbs prove a safe alternative to tetanus Ig for tetanus prevention and treatment in mice Dec. 23, 2021
ACE2-IgG4-Fc fusion protein neutralizes SARS-CoV-2, including several variants, at pM concentration Dec. 17, 2021
Nucleoside analogue sangivamycin shows in vitro activity against several variants of SARS-CoV-2 Dec. 16, 2021
RSS